Information - best new cancer treatments - bladder, brain, breast, cervical, colon, endometrial, kidney, liver, lung, ovarian, pancreatic, prostate, stomach tumors

A Very Promising but Ignored Cancer Treatment

New Cancer Therapy Alternative

     

GEIPE Home

 

GEIPE -
In A Nutshell

 

Scientific Articles

 

Testimonials & Correspondences
 

The Struggle
 

An Alternative Treatment
 

Cancer Cure?

Cancer & Genes
 

About Us


Contact Us

 

 

In a Nutshell

The Novel GEIPE Cancer Therapy

Enzymes control what takes place in a cell. The pivotal enzyme for the synthesis of DNA, and thus for cell growth, is RR (ribonucleotide reductase) since it supplies building blocks of DNA. Table-1 shows how critical is this enzyme for the growth of cancerous cells. Attempts are continuously being made to synthesize chemotherapeutic drugs that would selectively inhibit this enzyme, but with little success.

A novel way of blocking this enzyme is suggested by the fact that at the “core” (active-site) of this enzyme is a lone electron (free-radical) which is essential for its activity. Such free radicals can be neutralized or disabled by passing mild direct electric current through the tissue. Fortunately, in healthy cells, the free-radical containing active-site is too well shielded to be destroyed this way, but such does not seem to be the case in cancer cells where mutations abound and the enzyme RR is in over-drive. Thus, the gentle DC electrotherapy would act selectively on malignant growth.

The connection between low‑level DC electrotherapy and deactivation of enzyme RR is a recent proposal. However, use  of  low‑level direct electric currents to treat tumor -- without any clear understanding of the underlying mechanism ‑‑ have been reported in scientific literature at least ten times during the last 50 years. Results of all these studies are consistent with the proposed deactivation of the pivotal enzyme.

Outcome reported in three of these papers were very encouraging. For example, a study published in the prominent journal Cancer Research in 1985 reported 98% reduction in the tumor mass of lab animals -- a virtual cure. Please see Table-2.

Note: On contacting the head scientist Dr. Herbert of the 1985 study, it was discovered that he was denied funding to study the procedure further. Please see his letter in 'Testimonials & Correspondences'.

●●●

 

Note: Our GEIPE device is best suited for treating oral cancers (tongue, cheek, mouth, lip, chin, throat, neck), skin cancer, melanoma, carcinoma, breast cancer, buccal mucosa, lymphoma, tumors of forehead or temple and other visible or palpable cancers.

 ©2003 GEIPE - A Very Promising Cancer Treatment
● Los Angeles ● California ● USA